[ad_1]
Due to a newly fashioned partnership, PatientsLikeMe group well being community members could have entry to at-home diagnostics firm LetsGetChecked‘s choices and obtain reductions on screening assessments.
Mass.-based PatientsLikeMe is a personalised well being community that features a affected person help group, well being administration and a real-world knowledge platform. It emerged in 2004 as one of many early gamers within the digital well being house.
Based in 2015, LetsGetChecked provides at-home assessments, together with ones for sexual well being, diabetes, thyroid, ldl cholesterol and COVID-19.
“Healthcare shoppers at present expect elevated engagement and entry with regards to their care providers, and testing isn’t any exception. With the partnership between PatientsLikeMe and LetsGetChecked, our members can now count on enhanced capabilities with handy entry to at-home testing options, making certain people can obtain the care and help they want, once they want it,” Chris-Renfo Wallace, chief working officer of PatientsLikeMe, instructed MobiHealthNews in an e mail.
THE LARGER TREND
In 2017, PatientsLikeMe secured $100 million in funding, primarily from a partnership with well being knowledge and genomics firm iCarbonX, a enterprise based by scientist Jun Wang and closely backed by Chinese language mega-conglomerate Tencent.
In 2019, iCarbonX, the Chinese language agency holding the bulk stake within the firm, was ordered by the Treasury Division’s Committee on International Funding in america to divest its shares because of issues about international funding and affect, forcing PatientsLikeMe to hunt a brand new purchaser for its stake within the on-line community.
In 2019, PatientsLikeMe introduced it signed a cope with UnitedHealth Group to grow to be a part of the managed healthcare and insurance coverage firm’s analysis department, which sparked concerns about privacy and data sharing among the many public, notably seen on social media.
Final yr, the corporate introduced it acquired $26 million in funding
So far, the corporate has raised $153 million, in response to Crunchbase, and in October launched a uncommon illness research centered on Alpha-1 Antitrypsin Deficiency (AATD) with healthcare expertise firm SEQSTER.
LetsGetChecked has additionally garnered a considerable quantity of funding. In September, JP Morgan Chase’s healthcare enterprise unit, Morgan Well being, introduced a $20 million strategic investment in LetsGetChecked.
A yr earlier than, the distant diagnostics firm closed a $150 million Series D funding round, constructing on raises in 2018, 2019 and 2020.
[ad_2]
Source link
